GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunityBio Inc (FRA:26CA) » Definitions » Other Gross PPE

ImmunityBio (FRA:26CA) Other Gross PPE : €171.96 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is ImmunityBio Other Gross PPE?

ImmunityBio's Other Gross PPE for the quarter that ended in Dec. 2024 was €171.96 Mil.

ImmunityBio's quarterly Other Gross PPE declined from Jun. 2024 (€166.46 Mil) to Sep. 2024 (€163.18 Mil) but then increased from Sep. 2024 (€163.18 Mil) to Dec. 2024 (€171.96 Mil).

ImmunityBio's annual Other Gross PPE declined from Dec. 2022 (€172.23 Mil) to Dec. 2023 (€164.15 Mil) but then increased from Dec. 2023 (€164.15 Mil) to Dec. 2024 (€171.96 Mil).


ImmunityBio Other Gross PPE Historical Data

The historical data trend for ImmunityBio's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunityBio Other Gross PPE Chart

ImmunityBio Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial 86.42 135.47 172.23 164.15 171.96

ImmunityBio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 164.15 164.12 166.46 163.18 171.96

ImmunityBio Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


ImmunityBio Business Description

Traded in Other Exchanges
Address
3530 John Hopkins Court, San Diego, CA, USA, 92121
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

ImmunityBio Headlines

No Headlines